S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)

Abrdn Life Sciences Investors (HQL) Short Interest Ratio & Short Volume

$13.85
+0.03 (+0.22%)
(As of 02/26/2024 ET)

Abrdn Life Sciences Investors Short Interest Data

Current Short Volume
13,400 shares
Previous Short Volume
96,900 shares
Change Vs. Previous Month
-86.17%
Dollar Volume Sold Short
$183,848.00
Short Interest Ratio / Days to Cover
0.1
Last Record Date
January 31, 2024
Outstanding Shares
26,212,000 shares
Percentage of Shares Shorted
0.05%
Today's Trading Volume
72,466 shares
Average Trading Volume
138,286 shares
Today's Volume Vs. Average
52%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Abrdn Life Sciences Investors ?

Sign up to receive the latest short interest report for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

HQL Short Interest Over Time

HQL Days to Cover Over Time

HQL Percentage of Float Shorted Over Time


Abrdn Life Sciences Investors Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/202413,400 shares $183,848.00 -86.2%N/A0.1 $13.72
1/15/202496,900 shares $1.37 million +37.1%N/A0.8 $14.16
12/31/202370,700 shares $951,622.00 +30.2%N/A0.5 $13.46
12/15/202354,300 shares $714,045.00 +18.0%N/A0.4 $13.15
11/30/202346,000 shares $549,240.00 -51.0%N/A0.4 $11.94
11/15/202393,800 shares $1.13 million +186.0%N/A0.8 $12.04
10/31/202332,800 shares $380,152.00 -42.9%N/A0.3 $11.59
10/15/202357,400 shares $704,872.00 +71.9%N/A0.5 $12.28
9/30/202333,400 shares $416,498.00 -7.2%N/A0.3 $12.47
9/15/202336,000 shares $461,880.00 +40.1%N/A0.4 $12.83
8/31/202325,700 shares $334,357.00 +71.3%N/A0.3 $13.01
8/15/202315,000 shares $201,300.00 -63.0%N/A0.2 $13.42
7/31/202340,500 shares $544,725.00 +282.1%N/A0.4 $13.45
7/15/202310,600 shares $142,146.00 -85.7%N/A0.1 $13.41
6/30/202374,000 shares $1.00 million +695.7%N/A1 $13.55
6/15/20239,300 shares $128,712.00 No ChangeN/A0.1 $13.84
5/31/20239,300 shares $123,597.00 -76.6%N/A0.1 $13.29
5/15/202339,800 shares $559,588.00 -27.2%N/A0.5 $14.06
4/30/202354,700 shares $761,971.00 -2.0%N/A0.7 $13.93
4/15/202355,800 shares $782,874.00 -1.8%N/A0.7 $14.03
3/31/202356,800 shares $791,224.00 -45.8%N/A0.7 $13.93
3/15/2023104,700 shares $1.44 million +408.3%N/A1 $13.72
2/28/202320,600 shares $287,576.00 +186.1%N/A0.2 $13.96
2/15/20237,200 shares $105,336.00 -22.6%N/A0.1 $14.63
1/31/20239,300 shares $138,942.00 -17.7%N/A0.1 $14.94
1/15/202311,300 shares $166,788.00 -50.9%N/A0.1 $14.76
12/30/202223,000 shares $326,830.00 +62.0%N/A0.2 $14.21
12/15/202214,200 shares $209,024.00 -10.7%N/A0.1 $14.72
11/30/202215,900 shares $239,772.00 +28.2%N/A0.2 $15.08
11/15/202212,400 shares $186,620.00 +7.8%N/A0.1 $15.05
10/31/202211,500 shares $168,475.00 -62.9%N/A0.1 $14.65
10/15/202231,000 shares $427,490.00 No ChangeN/A0.4 $13.79
9/30/202224,000 shares $327,840.00 -33.9%N/A0.3 $13.66
9/15/202236,300 shares $537,240.00 +80.6%N/A0.5 $14.80
8/31/202220,100 shares $290,244.00 +55.8%N/A0.3 $14.44
8/15/202212,900 shares $210,399.00 +79.2%N/A0.2 $16.31
7/31/20227,200 shares $107,424.00 -77.1%N/A0.1 $14.92
7/15/202231,400 shares $475,082.00 +91.5%N/A0.4 $15.13
6/30/202216,400 shares $233,372.00 +11.6%N/A0.2 $14.23
6/15/202214,700 shares $198,156.00 +110.0%N/A0.2 $13.48













HQL Short Interest - Frequently Asked Questions

What is Abrdn Life Sciences Investors' current short interest?

Short interest is the volume of Abrdn Life Sciences Investors shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 13,400 shares of HQL short. Learn More on Abrdn Life Sciences Investors' current short interest.

Is Abrdn Life Sciences Investors' short interest increasing or decreasing?

Abrdn Life Sciences Investors saw a drop in short interest in January. As of January 31st, there was short interest totaling 13,400 shares, a drop of 86.2% from the previous total of 96,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Abrdn Life Sciences Investors' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "investment offices, not elsewhere classified" compare to Abrdn Life Sciences Investors: Putnam Premier Income Trust (0.10%), Putnam Municipal Opportunities Trust (0.19%), DWS Municipal Income Trust (0.11%), BlackRock MuniYield New York Quality Fund, Inc. (0.09%), Tortoise Energy Infrastructure Co. (0.14%), BlackRock MuniYield Michigan Quality Fund, Inc. (0.05%), Source Capital, Inc. (0.04%), BlackRock MuniHoldings New York Quality Fund, Inc. (0.20%), MFS Intermediate Income Trust (0.17%), BlackRock MuniAssets Fund, Inc. (0.54%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Abrdn Life Sciences Investors stock?

Short selling HQL is an investing strategy that aims to generate trading profit from Abrdn Life Sciences Investors as its price is falling. HQL shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Abrdn Life Sciences Investors?

A short squeeze for Abrdn Life Sciences Investors occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HQL, which in turn drives the price of the stock up even further.

How often is Abrdn Life Sciences Investors' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HQL, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NYSE:HQL) was last updated on 2/26/2024 by MarketBeat.com Staff